Results 21 to 30 of about 8,038 (216)
Background and study aims Among vasculitides, IgA vasculitis (IgAV) and eosinophilic granulomatosis with polyangiitis (EGPA) frequently damage the gastrointestinal tract.
Keisuke Kawasaki +15 more
doaj +1 more source
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Objectives Patients affected by eosinophilic granulomatosis with polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population.
Maria Letizia Urban +25 more
core +1 more source
Benralizumab: Resolution of Eosinophilic Pulmonary Vasculitis in a Patient With EGPA [PDF]
n ...
Bormioli, S +9 more
openaire +2 more sources
Otologic and rhinologic manifestations of EGPA [PDF]
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic autoimmune disease that manifests as asthma, recurrent sinusitis and peripheral eosinophilia.
Morita, Shinya +6 more
core +1 more source
Update on eosinophilic granulomatosis with polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) (formerly Churg-Strauss syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis characterized by eosinophil-rich granulomatous inflammation and small to medium-size ...
Shunsuke Furuta +2 more
doaj +1 more source
Insights from Social Media on the Patient Experience of Living With Rare Eosinophil-Driven Diseases
Eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES) are driven by persistently high eosinophil numbers, causing damage to tissues and organs.
Mary Jo Strobel +6 more
doaj +1 more source
Eosinophils play an important pathogenetic role in the development of eosinophilic granulomatosis with polyangiitis (EGPA). EGPA has long been treated with systemic corticosteroids and immunosuppressive agents.
Osamu Matsuno, Seijiro Minamoto
doaj +1 more source
Objective To investigate the clinical symptoms, the physical and neurological findings, and the clinical course of neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA). Methods A retrospective chart review of EGPA cases managed by two referral hospitals was performed, with a focus on the neurological findings.
Oiwa, Hiroshi +7 more
openaire +3 more sources
Two types of interleukin (IL)-5 antibody biologics, anti-IL-5 antibodies (mepolizumab) and anti-IL-5α receptor antibodies (benralizumab), are indicated for severe asthma.
Yasuhiko Koga +7 more
doaj +1 more source
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis involving small-to-medium-sized vessels characterized by asthma, vasculitis, and peripheral eosinophilia.
Hiroyuki Yamamoto +4 more
doaj +1 more source

